RWIBX
Price
$62.90
Change
+$0.23 (+0.37%)
Updated
Apr 2 closing price
Net Assets
122.78B
VHGEX
Price
$34.97
Change
+$0.29 (+0.84%)
Updated
Apr 2 closing price
Net Assets
7.77B
Ad is loading...

RWIBX vs VHGEX

Header iconRWIBX vs VHGEX Comparison
Open Charts RWIBX vs VHGEXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.90
Change+$0.23 (+0.37%)
VolumeN/A
Net Assets122.78B
Vanguard Global Equity I
Price$34.97
Change+$0.29 (+0.84%)
VolumeN/A
Net Assets7.77B
RWIBX vs VHGEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. VHGEX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and VHGEX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 123B vs. VHGEX (7.77B). VHGEX pays higher dividends than RWIBX: VHGEX (1.25) vs RWIBX (0.92). RWIBX was incepted earlier than VHGEX: RWIBX (23 years) vs VHGEX (30 years). RWIBX (1.51) is less costly to investors than VHGEX (0.39). VHGEX is a more actively managed with annual turnover of: 38.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than VHGEX: RWIBX (250) vs VHGEX (3000). VHGEX annual gain was more profitable for investors over the last year : 0.31 vs. RWIBX (0.05). RWIBX return over 5 years is better than : 64.01 vs. VHGEX (46.61).
RWIBXVHGEXRWIBX / VHGEX
Total Expense Ratio1.510.39387%
Annual Report Gross Expense Ratio1.510.39387%
Fund Existence23 years30 years-
Gain YTD0.679-2.420-28%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets123B7.77B1,584%
Annual Yield % from dividends0.921.2573%
Returns for 1 year0.050.3115%
Returns for 3 years10.51-0.57-1,833%
Returns for 5 years64.0146.61137%
Returns for 10 years38.2340.7394%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APVO1.380.38
+38.26%
Aptevo Therapeutics Inc
LCTX0.440.03
+6.37%
Lineage Cell Therapeutics
BIO245.525.52
+2.30%
Bio-Rad Laboratories IncClass A
HLLY2.57N/A
N/A
Holley
TR31.29-0.28
-0.89%
Tootsie Roll Industries Inc